Showing results (31-40 of 173) with videos related to
Sort By:
Pageof 18
Neuroscience Letters|July 13, 2004
Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) miceEd X Wu, Haiying Tang, Tomohiro Asai, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2024
Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatmentYao Qi, Shuai Lv, Changheng Xie, et al.Exploration (Beijing, China)|November 7, 2023
Adoptive cell therapy for cancer treatmentShi Du, Jingyue Yan, Yonger Xue, et al.Current Medicinal Chemistry|June 21, 2024
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 InhibitorsSi-Shi Du, Yu-Qing Fang, Wen Zhang, et al.Biochemical and Biophysical Research Communications|May 2, 2006
Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligandsDong-Qing Wei, Qi-Shi Du, Hao Sun, et al.Annals of Medicine|March 27, 2009
Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammationShi Fang Yan, Shi Du Yan, Ravichandran Ramasamy, et al.Advanced Drug Delivery Reviews|November 28, 2002
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settingsDavid Stern, Shi Du Yan, Shi Fang Yan, et al.Expert Opinion on Drug Discovery|June 1, 2012
Progress in structure-based drug design against influenza A virusQi-Shi Du, Hang Wei, Ri-Bo Huang, et al.Journal of Alzheimer'S Disease : JAD|April 24, 2009
RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?Shi Du Yan, Angelika Bierhaus, Peter P Nawroth, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|September 5, 2006
Molecular modeling studies of peptide drug candidates against SARSRui Zhang, Dong-Qing Wei, Qi-Shi Du, et al.Pageof 18